19:00-19:08 |
专题发言 |
Biological conduits for the management of infected aortic prosthesis: The Attikon University Hospital experience
|
Georgios Geroulakos |
Attikon University Hospital, Greece |
19:09-19:17 |
专题发言 |
Transfemoral access in branched EVAR(to be determined)
|
Tilo Kölbel |
University of Hamburg, Germany |
19:18-19:26 |
专题发言 |
Historical note on endovascular technologies
|
Jacques Busquet |
Clinique Chirurgicale Val d’Or, France |
19:27-19:35 |
专题发言 |
Does inter-hospital transfer impact mortality in patients with ruptured abdominal aortic aneurysm
|
Alexander Zimmermann |
University Hospital Zurich, Switzerland |
19:36-19:44 |
专题发言 |
Polyester stent graft devices and higher risk of post-implantation syndrome after EVAR
|
Arnaldo Ippoliti |
University of Rome "Tor Vergata", Italy |
19:45-19:53 |
专题发言 |
Role of IVUS during BEVAR
|
Michele Antonello |
Padua University Hospital, Italy |
19:54-20:02 |
专题发言 |
Total endovascular management of type a aortic dissection: state of art 2022
|
Antonio Rizza |
University of Pisa, Italy |
20:03-20:11 |
专题发言 |
A new techniques of endovascular reconstruction of aortic bifurcation-CERAB
|
Tomislav Krpan |
University Hospital Sestre Milosrdnice, Croatia |
20:12-20:20 |
专题发言 |
Our experience with Lifetech Ankura abdominal aortic stent graft
|
Nikola Kolev |
Military Medical Academy Sofia, Bulgaria |
20:21-20:29 |
专题发言 |
Treatment of thoracic pathologies involving the aortic arch at level of the LSA with TEVAR using the Ankura graft and in-situ fenestration
|
Marco Usai |
Franziskus Hospital Münster, Germany |
20:30-21:00 |
讨论 |
Discussion
|
|
|